Trending...
- UK Financial Ltd Confirms Official Corporate Structure of the Maya Preferred Project and Its Dual-Class Token System
- Daniel S. Romero, CFP® Earns Renowned Certification for Fiduciary Excellence
- California: Coho salmon are making a comeback in the Russian River for the first time in 30 years
For measuring RNase activity in buffers, reagents, and other components
MILPITAS, Calif. - May 17, 2019 - Californer -- Many molecular biology applications require RNase-free environment due to the degradation of RNA samples by RNase. Obtaining full length, high quality RNA samples are essential, yet challenging in genomics settings. BioVision's RNAse Activity Detection Assay Kit enables researchers to measure RNase activity in buffers, reagents, and other components as well as quantitatively evaluate RNAse activity of recombinant enzymes in real time. The assay uses a highly sensitive, specific probe that releases a fluorescent product in the presence of active RNAse. The limit of detection is 0.4 pg RNase/well and limit of quantification is 1.2 pg RNase/well. For accurate estimations, it is crucial to use molecular biology grade reagents (RNAse free) during sample preparation and RNAse barrier filter tips for sample pipetting at all times in order to avoid RNAse contamination.
More on The Californer
Figure: Sample kinetic curve obtained from Negative Control (Blank), bacterial culture, RNase contaminated BSA and purified RNase. Assays were performed following the kit protocol.
For more information on this kit, visit: https://www.biovision.com/rnase-activity-detection-quantification-assay-kit-fluorometric.html
More on The Californer
- Women's Everyday Safety Is Changing - The Blue Luna Shows How
- Microgaming Unveils Red Papaya: A New Studio Delivering Cutting-Edge, Feature-Rich Slots
- "Unwrap" This Bad Boy for Christmas - A New Home
- Community Commitment Advances Student Opportunity at Moorpark College
- Rachel Farris, CPA, Founder of Tax Stack AI, Featured in Boss Today on Ethical AI Leadership
Figure: Sample kinetic curve obtained from Negative Control (Blank), bacterial culture, RNase contaminated BSA and purified RNase. Assays were performed following the kit protocol.
For more information on this kit, visit: https://www.biovision.com/rnase-activity-detection-quantification-assay-kit-fluorometric.html
Source: BioVision Inc
Filed Under: Biotech
0 Comments
Latest on The Californer
- Milwaukee Job Corps Center Hosts Alumni Day, Calls Alumni to Action on Open Enrollment Campaign
- Connect Promotes Dr. Petra Stegmann as Head of Entrepreneurial Programs
- Xonicwave Expands Premier IT & Cybersecurity Services to San Diego Businesses
- Clean Comedy Kings Debuts At Black Oak Casino Saturday January 3rd
- Golden Paper Identifies Global Growth in Packaging Papers and Upgrades Its High-End Production Capacity
- Car Wash in Northridge CA Stays Open Late Until 10 PM
- Live Performance at the Bal Theater by Angel Sessions
- FASTMAX Launches Modern, AI-Enabled Tax Preparation for Everyday Americans
- CWEHBIT Exchange Expands System Transparency Framework
- AIXEBIT Exchange Launches Compliance Wall to Highlight Global Regulatory Alignment
- Champagne, Caviar Bumps & Pole Performances — Welcome the New Year Early with HandPicked Social Club
- A New Soul Album: Heart Of Kwanzaa, 7-Day Celebration
- Allegiant Management Group Named 2025 Market Leader in Orlando by PropertyManagement.com
- NAFMNP Awarded USDA Cooperative Agreement to Continue MarketLink Program Under FFAB
- Shore Scripts Announces Fall 2025 Short Film Fund Grant Recipients Al Benoit and Ericka Lavin
- California: Governor Newsom launches new initiatives to partner with tech policy experts and accelerate responsible AI in state government
- Costa Oil - 10 Minute Oil Change Surpasses 70 Locations with Construction of San Antonio, TX Stores — Eyes Growth Via Acquisition or Being Acquired
- LaTerra and Respark Under Contract with AIMCO to Acquire a $455M, 7-Property Chicago Multifamily Portfolio
- Record Revenue, Tax Tailwinds, and AI-Driven Scale: Why Off The Hook YS Inc. Is Emerging as a Standout in the $57 Billion U.S. Marine Market
- VSee Health (N A S D A Q: VSEE) Secures $6.0M At-Market Investment, Accelerates Expansion as Revenues Surge